Skip to main content

Published locations for FDA okays first sublingual med for agitation in serious mental illness

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA okays first sublingual med for agitation in serious mental illness

User login

  • Reset your password
  • /content/fda-okays-first-sublingual-med-agitation-serious-mental-illness
  • /fedprac/article/253648/schizophrenia-other-psychotic-disorders/fda-okays-first-sublingual-med
  • /psychiatry/article/253648/schizophrenia-other-psychotic-disorders/fda-okays-first-sublingual-med
  • /emergencymedicine/article/253648/schizophrenia-other-psychotic-disorders/fda-okays-first-sublingual
  • /clinicalpsychiatrynews/article/253648/schizophrenia-other-psychotic-disorders/fda-okays-first